Furthermore, according to an interesting study presented by Larrain et al., after serums of breast cancer patients that were combined with incubated breast tissues had different pathologic diagnosis such as normal, benign, and malignant, they found the reduction in anti-MUC1 antibody and antigen reactivity to be more in breast cancer tissues than benign breast tissues [25]. Here, MUC1 is linked to breast carcinoma.